{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:28:16Z","timestamp":1788881296601,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Changzhou Science and Technology Bureau applied basic research guidance project","award":["CJ20242039"],"award-info":[{"award-number":["CJ20242039"]}]},{"name":"Changzhou Science and Technology Bureau applied basic research guidance project","award":["CJ20242039"],"award-info":[{"award-number":["CJ20242039"]}]},{"name":"Changzhou Science and Technology Bureau applied basic research guidance project","award":["CJ20242039"],"award-info":[{"award-number":["CJ20242039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gastric cancer (GC) remains a significant global health challenge due to its high mortality and frequent resistance to chemotherapy drugs like cisplatin (DDP). Carnosic acid (CA), a phenolic diterpene, exhibits potential anti-cancer properties. This study aimed to investigate the role of CA in regulating GC development and DDP sensitivity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The half-maximal inhibitory concentration (IC<jats:sub>50<\/jats:sub>) of DDP and cell viability were determined using a cell counting kit-8 assay. Cell proliferation was evaluated by a 5-Ethynyl-2\u2019-deoxyuridine assay, while cell migration was assessed by a transwell assay. Cell death was analyzed through flow cytometry, fluorometric assay, and colorimetric assays. The targets of CA were identified using network pharmacology. Western blotting was employed to detect the protein expression of tumor protein p53 (TP53), solute carrier family 7 member 11 (SLC7A11), and arachidonate 12-lipoxygenase, 12\u00a0S type (ALOX12).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>CA treatment significantly inhibited GC cell proliferation and migration and enhanced cell death. The treatment also elevated reactive oxygen species (ROS) and Fe<jats:sup>2+<\/jats:sup> levels, while reducing glutathione (GSH) levels and the IC<jats:sub>50<\/jats:sub> value for DDP in GC cells. In addition, TP53 was identified as a target of CA, and its protein expression was upregulated by CA treatment in GC cells. Silencing TP53 attenuated the effects of CA on cell proliferation, migration, death, and the sensitivity of tumor cells to DDP. Further, CA regulated the TP53-mediated SLC7A11\/ALOX12 pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>CA improved the sensitivity of GC cells to DDP and inhibited their malignant progression by regulating the TP53-mediated SLC7A11\/ALOX12 axis, highlighting its potential clinical significance for GC treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00508-2","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T02:54:19Z","timestamp":1753239259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Carnosic acid enhances cisplatin sensitivity and suppresses gastric cancer progression via the TP53\/SLC7A11\/ALOX12 axis"],"prefix":"10.1186","volume":"162","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"3","key":"508_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"508_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","volume":"52","author":"M Alipour","year":"2021","unstructured":"Alipour M. Molecular mechanism of Helicobacter pylori-Induced gastric Cancer. J Gastrointest Cancer. 2021;52(1):23\u201330.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"508_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"508_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/0118744710267281231104170435","volume":"17","author":"A Maryam","year":"2024","unstructured":"Maryam A, Zahra S, Soghra F, Zeynab M. Radioprotective potency of nanoceria. Curr Radiopharmaceuticals. 2024;17(2):138\u201347.","journal-title":"Curr Radiopharmaceuticals"},{"key":"508_CR5","doi-asserted-by":"crossref","unstructured":"Badie A, Gaiddon C, Mellitzer G. Histone deacetylase functions in gastric Cancer. Therapeutic Target? Cancers 2022;14(21):5472.","DOI":"10.3390\/cancers14215472"},{"issue":"5","key":"508_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00280-023-04572-1","volume":"92","author":"C Liu","year":"2023","unstructured":"Liu C, Li S, Tang Y. Mechanism of cisplatin resistance in gastric cancer and associated MicroRNAs. Cancer Chemother Pharmacol. 2023;92(5):329\u201340.","journal-title":"Cancer Chemother Pharmacol"},{"key":"508_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"2","key":"508_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289\u201392.","journal-title":"Chin J Cancer Res"},{"key":"508_CR9","doi-asserted-by":"publisher","first-page":"107288","DOI":"10.1016\/j.phrs.2024.107288","volume":"206","author":"X Chen","year":"2024","unstructured":"Chen X, Wei C, Zhao J, Zhou D, Wang Y, Zhang S, Zuo H, Dong J, Zhao Z, Hao M, et al. Carnosic acid: an effective phenolic diterpenoid for prevention and management of cancers via targeting multiple signaling pathways. Pharmacol Res. 2024;206:107288.","journal-title":"Pharmacol Res"},{"key":"508_CR10","doi-asserted-by":"crossref","unstructured":"Mirza FJ, Zahid S, Holsinger RMD. Neuroprotective effects of carnosic acid: insight into its mechanisms of action. Molecules 2023;28(5):2306.","DOI":"10.3390\/molecules28052306"},{"key":"508_CR11","doi-asserted-by":"publisher","first-page":"119257","DOI":"10.1016\/j.jep.2024.119257","volume":"340","author":"L Zhang","year":"2025","unstructured":"Zhang L, Liu S, Ding K, Zeng B, Li B, Zhou J, Li J, Wang J, Su X, Sun R. Yanghe Decoction inhibits inflammation-induced lung metastasis of colorectal cancer. J Ethnopharmacol. 2025;340:119257.","journal-title":"J Ethnopharmacol"},{"key":"508_CR12","doi-asserted-by":"publisher","first-page":"156591","DOI":"10.1016\/j.phymed.2025.156591","volume":"140","author":"Y Li","year":"2025","unstructured":"Li Y, Yang G, Li Q, Zhang Y, Zhang S, Zhou T, Wang X, Liu F, Miao Z, Qi Y, et al. Guiqi Baizhu Decoction enhances radiosensitivity in non-small cell lung cancer by inhibiting the HIF-1\u03b1\/DNA-PKcs axis-mediated DNA repair. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2025;140:156591.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"issue":"Pt 2","key":"508_CR13","doi-asserted-by":"publisher","first-page":"119071","DOI":"10.1016\/j.jep.2024.119071","volume":"338","author":"Y Sang","year":"2025","unstructured":"Sang Y, Hu Y, Zhang Y, Chen L, Lu Y, Gao L, Lu Y, Cao X, Zhang Y, Chen G. Network pharmacology, molecular Docking and biological verification to explore the potential anti-prostate cancer mechanisms of tripterygium wilfordii hook. F. J Ethnopharmacol. 2025;338(Pt 2):119071.","journal-title":"J Ethnopharmacol"},{"key":"508_CR14","doi-asserted-by":"crossref","unstructured":"O\u2019Neill EJ, Sze NSK, MacPherson REK, Tsiani E. Carnosic acid against lung cancer: induction of autophagy and activation of Sestrin-2\/LKB1\/AMPK signalling. Int J Mol Sci 2024;25(4):1950.","DOI":"10.3390\/ijms25041950"},{"key":"508_CR15","doi-asserted-by":"crossref","unstructured":"Nadile M, Sze NSK, Fajardo VA, Tsiani E. Inhibition of prostate Cancer cell survival and proliferation by carnosic acid is associated with Inhibition of Akt and activation of AMPK signaling. Nutrients 2024;16(9):1257.","DOI":"10.3390\/nu16091257"},{"key":"508_CR16","doi-asserted-by":"crossref","unstructured":"El-Huneidi W, Bajbouj K, Muhammad JS, Vinod A, Shafarin J, Khoder G, Saleh MA, Taneera J, Abu-Gharbieh E. Carnosic acid induces apoptosis and inhibits akt\/mtor signaling in human gastric Cancer cell lines. Pharmaceuticals (Basel) 2021;14(3):230.","DOI":"10.3390\/ph14030230"},{"key":"508_CR17","doi-asserted-by":"publisher","first-page":"101821","DOI":"10.1016\/j.mcp.2022.101821","volume":"64","author":"L Han","year":"2022","unstructured":"Han L, Li L, Wu G. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2\/HO-1 potentiates cisplatin responsiveness in OSCC cells. Mol Cell Probes. 2022;64:101821.","journal-title":"Mol Cell Probes"},{"issue":"2","key":"508_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discovery. 2023;22(2):127\u201344.","journal-title":"Nat Rev Drug Discovery"},{"key":"508_CR19","doi-asserted-by":"crossref","unstructured":"Capuozzo M, Santorsola M, Bocchetti M, Perri F, Cascella M, Granata V, Celotto V, Gualillo O, Cossu AM, Nasti G et al.: p53: from fundamental biology to clinical applications in Cancer. Biology 2022;11(9):1325.","DOI":"10.3390\/biology11091325"},{"key":"508_CR20","doi-asserted-by":"crossref","unstructured":"Voskarides K, Giannopoulou N. The role of TP53 in adaptation and evolution. Cells 2023;12(3):512.","DOI":"10.3390\/cells12030512"},{"key":"508_CR21","doi-asserted-by":"publisher","first-page":"215803","DOI":"10.1016\/j.canlet.2022.215803","volume":"544","author":"YH Hong","year":"2022","unstructured":"Hong YH, Aziz N, Park JG, Lee D, Kim JK, Kim SA, Choi W, Lee CY, Lee HP, Huyen Trang HT, et al. The EEF1AKMT3\/MAP2K7\/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer. Cancer Lett. 2022;544:215803.","journal-title":"Cancer Lett"},{"key":"508_CR22","doi-asserted-by":"crossref","unstructured":"Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric cancer: pathogenetic mechanisms. Int J Mol Sci 2023;24(3):2895.","DOI":"10.3390\/ijms24032895"},{"issue":"2","key":"508_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/0115701646302487240524103934","volume":"21","author":"D Viana","year":"2024","unstructured":"Viana D, Fatemeh Z, Simin N, Fatemeh N. An immunoinformatic approach to designing a Multi-epitope vaccine against <\u2009i\u2009>\u2009helicobacter pylori\u2009with the VacA toxin and BabA adhesion. Curr Proteomics. 2024;21(2):97\u2013112.","journal-title":"Curr Proteomics"},{"issue":"1","key":"508_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-020-01219-0","volume":"19","author":"L Yuan","year":"2020","unstructured":"Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ, Cheng XD. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer. 2020;19(1):96.","journal-title":"Mol Cancer"},{"issue":"6","key":"508_CR25","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1111\/jcmm.15055","volume":"24","author":"X Wang","year":"2020","unstructured":"Wang X, Xu Z, Sun J, Lv H, Wang Y, Ni Y, Chen S, Hu C, Wang L, Chen W, et al. Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition. J Cell Mol Med. 2020;24(6):3625\u201333.","journal-title":"J Cell Mol Med"},{"issue":"17","key":"508_CR26","doi-asserted-by":"publisher","first-page":"e37046","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, Zou Y, Jia J, Li H, Feng Z, Zhang G, Yao M. Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon. 2024;10(17):e37046.","journal-title":"Heliyon"},{"key":"508_CR27","doi-asserted-by":"crossref","unstructured":"Khella KF, Abd El Maksoud AI, Hassan A, Abdel-Ghany SE, Elsanhoty RM, Aladhadh MA, Abdel-Hakeem MA. Carnosic acid encapsulated in albumin nanoparticles induces apoptosis in breast and colorectal Cancer cells. Molecules 2022;27(13):4102.","DOI":"10.3390\/molecules27134102"},{"issue":"8","key":"508_CR28","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41416-024-02825-1","volume":"131","author":"Y Gu","year":"2024","unstructured":"Gu Y, Sun M, Fang H, Shao F, Lin C, Liu H, Li H, He H, Li R, Wang J, et al. Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. Br J Cancer. 2024;131(8):1320\u20137.","journal-title":"Br J Cancer"},{"key":"508_CR29","doi-asserted-by":"crossref","unstructured":"Guan Z, Chen J, Li X, Dong N. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep 2020;40(8):BSR20201807.","DOI":"10.1042\/BSR20201807"},{"issue":"5","key":"508_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, Song S, Tavana O, Gu W. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol. 2019;21(5):579\u201391.","journal-title":"Nat Cell Biol"},{"key":"508_CR31","doi-asserted-by":"crossref","unstructured":"Zhang S, Deng S, Liu J, Liu S, Chen Z, Liu S, Xue C, Zeng L, Zhao H, Xu Z et al. Targeting MXD1 sensitises pancreatic cancer to Trametinib. Gut 2025;74(8):1262-78.","DOI":"10.1136\/gutjnl-2024-333408"},{"issue":"1","key":"508_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","volume":"20","author":"S Abdolahi","year":"2022","unstructured":"Abdolahi S, Ghazvinian Z, Muhammadnejad S, Saleh M, Asadzadeh Aghdaei H, Baghaei K. Patient-derived xenograft (PDX) models, applications and challenges in cancer research. J Transl Med. 2022;20(1):206.","journal-title":"J Transl Med"},{"issue":"1","key":"508_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023;8(1):160.","journal-title":"Signal Transduct Target Ther"},{"key":"508_CR34","doi-asserted-by":"publisher","first-page":"633916","DOI":"10.3389\/fonc.2021.633916","volume":"11","author":"R Xia","year":"2021","unstructured":"Xia R, Zhou Y, Wang Y, Yuan J, Ma X. Hepatoid adenocarcinoma of the stomach: current perspectives and new developments. Front Oncol. 2021;11:633916.","journal-title":"Front Oncol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00508-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00508-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00508-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T18:42:10Z","timestamp":1757270530000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00508-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00508-2","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}